Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers

Bibliographic Details
Main Authors: Raquel López-Rodríguez, Irina Bobolea, Carlos Melero, Manuel J. Rial
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Allergy
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2024.1357886/full
_version_ 1797334664396931072
author Raquel López-Rodríguez
Irina Bobolea
Irina Bobolea
Carlos Melero
Manuel J. Rial
Manuel J. Rial
author_facet Raquel López-Rodríguez
Irina Bobolea
Irina Bobolea
Carlos Melero
Manuel J. Rial
Manuel J. Rial
author_sort Raquel López-Rodríguez
collection DOAJ
first_indexed 2024-03-08T08:24:23Z
format Article
id doaj.art-5848298eead44f5882775bdb07625307
institution Directory Open Access Journal
issn 2673-6101
language English
last_indexed 2024-03-08T08:24:23Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Allergy
spelling doaj.art-5848298eead44f5882775bdb076253072024-02-02T04:52:03ZengFrontiers Media S.A.Frontiers in Allergy2673-61012024-02-01510.3389/falgy.2024.13578861357886Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkersRaquel López-Rodríguez0Irina Bobolea1Irina Bobolea2Carlos Melero3Manuel J. Rial4Manuel J. Rial5Department of Allergy, Lucus Augusti University Hospital, Lugo, SpainDepartment of Allergy, Institut Clínic Respiratorio, Hospital Clinic of Barcelona, Barcelona, SpainNetwork Biomedical Research Center for Respiratory Diseases, Carlos III Health Institute (ISCIII), Madrid, SpainDepartment of Pulmonology, Research Institute Hospital 12 de Octubre, Madrid, SpainNetwork Biomedical Research Center for Respiratory Diseases, Carlos III Health Institute (ISCIII), Madrid, SpainDepartment of Allergy, A Coruña University Hospital Complex (CHUAC), A Coruña, Spainhttps://www.frontiersin.org/articles/10.3389/falgy.2024.1357886/fullasthmamonoclonal antibodiessevere asthmabiomarkersFeNO (Fraction of exhaled Nitric Oxide)
spellingShingle Raquel López-Rodríguez
Irina Bobolea
Irina Bobolea
Carlos Melero
Manuel J. Rial
Manuel J. Rial
Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
Frontiers in Allergy
asthma
monoclonal antibodies
severe asthma
biomarkers
FeNO (Fraction of exhaled Nitric Oxide)
title Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
title_full Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
title_fullStr Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
title_full_unstemmed Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
title_short Editorial: A multidisciplinary approach to treatment of severe chronic airway disease (CAD): focus on biomarkers
title_sort editorial a multidisciplinary approach to treatment of severe chronic airway disease cad focus on biomarkers
topic asthma
monoclonal antibodies
severe asthma
biomarkers
FeNO (Fraction of exhaled Nitric Oxide)
url https://www.frontiersin.org/articles/10.3389/falgy.2024.1357886/full
work_keys_str_mv AT raquellopezrodriguez editorialamultidisciplinaryapproachtotreatmentofseverechronicairwaydiseasecadfocusonbiomarkers
AT irinabobolea editorialamultidisciplinaryapproachtotreatmentofseverechronicairwaydiseasecadfocusonbiomarkers
AT irinabobolea editorialamultidisciplinaryapproachtotreatmentofseverechronicairwaydiseasecadfocusonbiomarkers
AT carlosmelero editorialamultidisciplinaryapproachtotreatmentofseverechronicairwaydiseasecadfocusonbiomarkers
AT manueljrial editorialamultidisciplinaryapproachtotreatmentofseverechronicairwaydiseasecadfocusonbiomarkers
AT manueljrial editorialamultidisciplinaryapproachtotreatmentofseverechronicairwaydiseasecadfocusonbiomarkers